Stephen M. Coutts
Profile
Stephen M.
Coutts is the founder of Triad Therapeutics, Inc. Prior to founding Triad Therapeutics, he worked as the President & Chief Executive Officer at Biocept, Inc., Director-Pharmaceutical Development at Cypress Bioscience, Inc., and Executive Vice President-Research & Development at La Jolla Pharmaceutical Co. Coutts holds a doctorate from Harvard University, an undergraduate degree from San Diego State University, and an MBA from New York University.
Former positions of Stephen M. Coutts
| Companies | Position | End |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Tech/Sci/R&D Officer | - |
| BIOCEPT, INC. | Chief Executive Officer | - |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Triad Therapeutics, Inc.
 Triad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders Triad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA. | Founder | - |
Training of Stephen M. Coutts
| Harvard University | Doctorate Degree |
| San Diego State University | Undergraduate Degree |
| New York University | Masters Business Admin |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| BIOCEPT, INC. | Health Technology |
| Private companies | 3 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Triad Therapeutics, Inc.
Triad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders Triad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen M. Coutts
